Average Co-Inventor Count = 5.27
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (14 from 1,970 patents)
2. Kezar Life Sciences (7 from 9 patents)
3. Onyx Therapeutics, Inc. (5 from 50 patents)
4. Genesoft Pharmaceuticals, Inc. (3 from 9 patents)
5. Other (1 from 832,680 patents)
6. University of California (1 from 15,458 patents)
7. Japan Tobacco Inc. (1 from 1,037 patents)
31 patents:
1. 11976053 - Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof
2. 11891383 - Crystalline salts of peptide epoxyketone immunoproteasome inhibitor
3. 11498907 - Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof
4. 11479548 - Crystalline salts of peptide epoxyketone immunoproteasome inhibitor
5. 11339193 - CDP protein secretion inhibitors
6. 11078233 - Tripeptide epoxy ketone protease inhibitors
7. 10836756 - Crystalline salts of peptide epoxyketone immunoproteasome inhibitor
8. 10781192 - Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof
9. 10647744 - Tripeptide epoxy ketone protease inhibitors
10. RE47302 - Peptide epoxyketone immunoproteasome inhibitors
11. 9657057 - Dipeptide and tripeptide epoxy ketone protease inhibitors
12. 9593129 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
13. 9434761 - Tripeptide epoxy ketone protease inhibitors
14. 9296736 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
15. 8980903 - Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors